Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PROTO-ONCOGENE PROTEINS C-MYC - GENETICS , . Treffer: 11

2017

Gürtl-Lackner, B; Gisselsson-Nord, D; Vujanic, G [Solid pediatric tumors : A brief survey of the rarity cabinet].
Pathologe. 2017; 38(4):278-285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Arvidsson, Y; Johanson, V; Pfragner, R; Wängberg, B; Nilsson, O Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells.
Neuroendocrinology. 2016; 103(5):578-591
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Ortega, M; Bhatnagar, H; Lin, AP; Wang, L; Aster, JC; Sill, H; Aguiar, RC A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.
Leukemia. 2015; 29(4):968-976 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zhao, Q; Assimopoulou, AN; Klauck, SM; Damianakos, H; Chinou, I; Kretschmer, N; Rios, JL; Papageorgiou, VP; Bauer, R; Efferth, T Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
Oncotarget. 2015; 6(36):38934-38951 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Ye, M; Zhang, H; Amabile, G; Yang, H; Staber, PB; Zhang, P; Levantini, E; Alberich-Jorda, M; Zhang, JY; Kawasaki, A; Tenen, DG; C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence.
Nat Cell Biol. 2013; 15(4):385-394 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Lohberger, B; Rinner, B; Stuendl, N; Absenger, M; Liegl-Atzwanger, B; Walzer, SM; Windhager, R; Leithner, A Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
PLoS One. 2012; 7(8):e43664-e43664 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Deutsch, AJ; Frühwirth, M; Aigelsreiter, A; Cerroni, L; Neumeister, P Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
J Invest Dermatol. 2009; 129(2): 476-479. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Kidd, M; Modlin, IM; Pfragner, R; Eick, GN; Champaneria, MC; Chan, AK; Camp, RL; Mane, SM Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
CANCER. 2007; 109(12): 2420-2431. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rutkowski, S; von Bueren, A; von Hoff, K; Hartmann, W; Shalaby, T; Deinlein, F; Warmuth-Metz, M; Soerensen, N; Emser, A; Bode, U; Mittler, U; Urban, C; Benesch, M; Kortmann, RD; Schlegel, PG; Kuehl, J; Pietsch, T; Grotzer, M Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
Clin Cancer Res. 2007; 13(9): 2651-2657. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Peris, K; Cerroni, L; Kerl, H; Radaszkiewicz, T; Chimenti, S; Höfler, H Expression of c-myc in cutaneous lymphomas and pseudolymphomas.
DERMATOLOGICA 1991 183: 1-6.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum